COVID-19 Research in CMM
As leading experts, using cutting-edge facilities and by developing unique partnerships, the School of Cellular and Molecular Medicine was ready and able to address the challenges posed by coronavirus (COVID-19). In this series of short films, our scientists discuss how they adapted their work and applied their knowledge to support global research efforts into the COVID-19 pandemic.
A timeline of COVID-19 research at Bristol in 2020
Experts from across the University of Bristol are playing a key role in global efforts to understand COVID-19 and help our communities tackle the pandemic. This timeline shows some of our research highlights since the beginning of the outbreak. Find out more about our response to the coronavirus pandemic.
Improving drug delivery: Allison Blair
Allison Blair, Associate Professor in Experimental Haematology in the University of Bristol's School of Cellular and Molecular Medicine discusses her team's work to adapt cancer drug delivery systems to help fight COVID-19. Find out more about Allison Blair.
Stopping secondary infections: Ruth Massey
Ruth Massey, Professor of Microbial Pathogenicity in the University of Bristol's School of Cellular and Molecular Medicine, discusses her team's work to improve tests for dangerous secondary infections in COVID-19 patients. Find out more about Ruth Massey.
Understanding the immune response: Fernando Ponce
Fernando Ponce, PhD candidate in the University of Bristol's School of Cellular and Molecular Medicine, discusses his work to understand the role of neutrophils (a key form of white blood cell and the first line of defence against infection) in the body's immune response to SARS-CoV2. Find out more about the Amulic Lab.
Modelling infection in human cells: Darryl Hill
Dr Darryl Hill, Associate Professor in Infectious Diseases at the University of Bristol's School of Cellular and Molecular Medicine, discusses his team's work to develop improved human cell models that can be used to study SARS-CoV2 infection. Find out more about Darryl Hill.
Identifying new drugs: Jim Spencer and Charlotte Colenso
Jim Spencer, Professor of Bacteriology and Charlotte Colenso, Postdoctoral Research Associate, in the University of Bristol's School of Cellular and Molecular Medicine. They explain their latest research using high-performance computing to identify new and exsisting drugs that could be used to treat COVID-19 infections. Find out more about Jim Spencer and Charlotte Colenso.
Stem cell therapies: Karen Still
Karen Still, Senior Research Associate in the University of Bristol's School of Cellular and Molecular Medicine, discusses her work to understand the role of stem cell therapies in reducing lung damage in patients with COVID-19. Find out more about Karen Still.